Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Kao Develops New Ingredients Effective against Wrinkles
August 27, 2001
- Korosho Asks Bayer, Takeda to Take Safety Measures Regarding Cerivastatin
August 27, 2001
- Efco, Kyuyukai Postpone Merger to Next Fiscal Year
August 27, 2001
- Korosho to Listen to Industry's Opinions on Amending PAL
August 27, 2001
- Pharmacists Are Absent from 64% of Stores Selling Drugs at Night
August 27, 2001
- Price Adjustment Method No Longer Functions Properly: Mr Fujii, New Diet Member
August 27, 2001
- OCT NEWS IN BRIEF
August 27, 2001
- Economic Reform Should Not Affect Quality of Social Security Services: Mr Takemi, Lower House Member
August 27, 2001
- Yamanouchi Discovers Immunocompetent Cell Activating Gene
August 27, 2001
- Canopus Develops New Image Distribution System for Hospitals
August 20, 2001
- BUSINESS NEWS IN BRIEF -1-
August 20, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 20, 2001
- BUSINESS NEWS IN BRIEF -2-
August 20, 2001
- Takara Launches 2 Additional DNA Chips
August 20, 2001
- Savings of \1.4 Trillion Possible by Reducing Drug Cost to 16%: Council Report
August 20, 2001
- Study on Diagnostic Method Using PALSAR Selected by JHSF
August 20, 2001
- 6th Designation for Quality Reevaluation Approved
August 20, 2001
- Takeda, Pharmacia to Launch Smoking Cessation Aid Nicorette in September
August 20, 2001
- Tiracoxib Designated as Orphan for Familial Adenomatous Polyposis
August 20, 2001
- Asahi Kasei Licenses Out Fasudil to Schering AG
August 20, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…